These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15515539)

  • 41. Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer.
    Ishii K; Tashiro M; Hosono M; Fukuda H; Takada Y; Kondo S; Inoue Y; Iguchi H; Kusuki M; Yamane H
    Acta Otolaryngol Suppl; 2004 Oct; (554):62-6. PubMed ID: 15513514
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacodynamics of taxol in human head and neck tumors.
    Gan Y; Wientjes MG; Schuller DE; Au JL
    Cancer Res; 1996 May; 56(9):2086-93. PubMed ID: 8616855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proliferation and clonal survival of human lung cancer cells treated with fractionated irradiation in combination with paclitaxel.
    van Rijn J; van den Berg J; Meijer OW
    Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):635-9. PubMed ID: 7558953
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cancer stem cells promotes resistance of laryngeal squamous cancer to irradiation mediated by hypoxia].
    Wang M; Li X; Lu X; Qu Y; Xu O; Sun Q
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Sep; 25(18):823-6. PubMed ID: 22256736
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting angiogenic processes by combination low-dose paclitaxel and radiation therapy.
    Dicker AP; Williams TL; Iliakis G; Grant DS
    Am J Clin Oncol; 2003 Jun; 26(3):e45-53. PubMed ID: 12796615
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Murine intestinal crypt survival after combined taxol plus radiation exposure.
    Lojun SL; Sigdestad CP; Connor AM; Spanos WJ; Bosscher JR
    Gynecol Oncol; 1996 Nov; 63(2):180-3. PubMed ID: 8910624
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Taxol sensitizes human astrocytoma cells to radiation.
    Tishler RB; Geard CR; Hall EJ; Schiff PB
    Cancer Res; 1992 Jun; 52(12):3495-7. PubMed ID: 1350755
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction of paclitaxel (Taxol) and irradiation. In-vitro differences between tumor and fibroblastic cells.
    Cordes N; Plasswilm L; Sauer R
    Strahlenther Onkol; 1999 Apr; 175(4):175-81. PubMed ID: 10230460
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combined modality treatment of laryngeal squamous cell carcinoma.
    Devlin JG; Langer CJ
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):331-50. PubMed ID: 17338653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Taxol and radiation.
    Geard CR; Jones JM; Schiff PB
    J Natl Cancer Inst Monogr; 1993; (15):89-94. PubMed ID: 7912535
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Down-regulation of p21Waf-1 protein facilitates IR- and UV-induced apoptosis in human squamous carcinoma cells.
    Izumaru S; Arima N; Toyozumi Y; Kato S; Morimatsu M; Nakashima T
    Int J Oncol; 2004 May; 24(5):1245-55. PubMed ID: 15067348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Schedule-dependent interaction of paclitaxel (Taxol) and irradiation in vitro.
    Plasswilm L; Cordes N; Sauer R
    Radiat Oncol Investig; 1998; 6(1):10-7. PubMed ID: 9503485
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term observations and salvage operations on patients with T2N0M0 squamous cell carcinoma of the glottic larynx treated with radiation therapy alone.
    Furusaka T; Matuda H; Saito T; Katsura Y; Ikeda M
    Acta Otolaryngol; 2012 May; 132(5):546-51. PubMed ID: 22264025
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Paclitaxel (Taxol) in chemotherapy of head and neck cancer--just another proposal or breakthrough?].
    Górecka KM; Golusiński W; Gawecki W; Szyfter K
    Otolaryngol Pol; 2001; 55(5):471-6. PubMed ID: 11868318
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effect of Notch1 on cell cycle, apoptosis and migration of laryngeal squamous cell carninoma cell line Hep-2].
    Jiao J; Li S
    Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):104-9. PubMed ID: 22780927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Disruption of p53 function in immortalized human cells does not affect survival or apoptosis after taxol or vincristine treatment.
    Fan S; Cherney B; Reinhold W; Rucker K; O'Connor PM
    Clin Cancer Res; 1998 Apr; 4(4):1047-54. PubMed ID: 9563901
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The enhancement of tumor radioresponse by combined treatment with cepharanthine is accompanied by the inhibition of DNA damage repair and the induction of apoptosis in oral squamous cell carcinoma.
    Harada T; Harada K; Ueyama Y
    Int J Oncol; 2012 Aug; 41(2):565-72. PubMed ID: 22664937
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhancement of radiation response of prostatic carcinoma by taxol: therapeutic potential for late-stage malignancy.
    Lokeshwar BL; Ferrell SM; Block NL
    Anticancer Res; 1995; 15(1):93-8. PubMed ID: 7733649
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Combined effect of Paclitaxel and ionizing radiation. Experimental data of in-vitro and in-vivo models].
    Rübe C; Hampel G; Schuck A; Willich N
    Strahlenther Onkol; 1996 May; 172 Suppl 1():2-5. PubMed ID: 8633269
    [No Abstract]   [Full Text] [Related]  

  • 60. A phase I trial of radiotherapy and simultaneous 24-hour paclitaxel in patients with locally advanced head and neck squamous cell carcinoma.
    Steinberg L; Hassan M; Olmsted L; Sharan V; Stepnick D; Hoppel C; Mugharbil A; Subramanyan S; McGloin B; Mackay W; Strauss M
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-51-S19-56. PubMed ID: 9427267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.